Zimmer Biomet Holdings, Inc.

ZBH Healthcare Medical Devices

Zimmer Biomet Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.2 billion, up 7.20% from fiscal 2024. In the quarter to June 2026, revenue grew 4.80%, EPS grew 33.8%, free cash flow grew 13.1% and total debt fell 1.23%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five.

95.06 0.68 +0.72%
Market cap
$18.0B
P/E
23.0×
Fwd P/E
17.7×
Dividend yield
1.01%
F-score
6/9
Altman Z
2.38
Beneish M
−2.59
Dividend safety
72/100

Zimmer Biomet Holdings, Inc. (ZBH) EV/FCF

Alert me on EV/FCF

As of 16 October 2026, Zimmer Biomet Holdings, Inc. (ZBH) trades at a EV/FCF of 24.4×. Over the past ten years it has ranged from 21.1× (December 2018) to 141× (April 2021); the current reading is higher than 12% of that period.

EV/FCF, daily

Embed this chart

Annual newest first

Period EV/FCF Change
FY2025 23.0× (33.78%)
FY2024 34.7× (1.11%)
FY2023 35.1× (4.49%)
FY2022 36.7× 10.75%
FY2021 33.1× (56.15%)
FY2020 75.6× 63.81%
FY2019 46.1× 108.94%
FY2018 22.1× (29.13%)
FY2017 31.2× 11.94%
FY2016 27.8× (59.78%)

Quarterly newest first

Period EV/FCF Change
Jun 2026 22.8× (6.93%)
Mar 2026 24.5× 6.64%
Dec 2025 23.0× (11.84%)
Sep 2025 26.0× 7.13%
42 more quarters

Against its own ten years

Low 21.1× High 141×
Ten-year median 32.4×
Current reading's percentile 13

EV/FCF against peers

What EV/FCF is

EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))

The full definition of EV/FCF →

More on ZBH